Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in SIADH (SAND Study)
NCT02874807Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Sep 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in syndrome of inappropriate antidiuretic hormone secretion (SIADH), sponsored by University Hospital Basel. Started Sep 2016; status: completed.
02
Drugs
empagliflozin
03
Conditions
syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Beyond the preview
Go deeper on NCT02874807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02874807.